Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
Find the latest Fresenius SE & Co. KGaA (FSNUF) stock quote, history, news and other vital information to help you with your stock trading and investing.
A high-level overview of Fresenius Medical Care AG (FMS) stock. View (FMS) real-time stock price, chart, news, analysis, analyst reviews and more.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback